- Investing Ideas
- South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
South Korean Pharmaceuticals & Biotech Healthy potentially undervalued
Results
4
0 new
Companies which are potentially undervalued and in an acceptable financial position.
4 companies
Hugel
Market Cap: ₩2.9t
Develops and manufactures biopharmaceuticals in South Korea and internationally.
A145020
₩267,500.00
7D
-5.3%
1Y
-25.6%
Dong-A Socio Holdings
Market Cap: ₩613.8b
Engages in the pharmaceutical business in South Korea.
A000640
₩92,600.00
7D
-2.7%
1Y
-7.3%
Dong-A ST
Market Cap: ₩402.8b
Develops, manufactures, and markets pharmaceutical products in South Korea and internationally.
A170900
₩41,900.00
7D
-0.1%
1Y
-6.4%
PharmaResearch
Market Cap: ₩3.2t
Operates as a biopharmaceutical company primarily in South Korea.
A214450
₩305,000.00
7D
-7.0%
1Y
-32.2%